Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 16,514 shares at $52.80 ($869K) on 2007-02-15, disclosed to the SEC on 2007-02-20.
Scheduled sale ($869k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.70 | 8,366 | $441K | 50.7% |
| 2 | $52.80 | 2,200 | $116K | 13.4% |
| 3 | $52.49 | 2,449 | $129K | 14.8% |
| 4 | $52.49 | 980 | $51K | 5.9% |
| 5 | $52.49 | 2,519 | $132K | 15.2% |
| Total | $52.64 avg | 16,514 |
| $869K |
| 100% |
| Filing → |
| ABT | SELL | 2012-03-02 | $4.6M | — | Filing → |
| ABT | SELL | 2011-12-16 | $4.2M | — | Filing → |
| ABT | SELL | 2011-03-02 | $75K | — | Filing → |